Published in Infect Immun on April 01, 1995
Correlation of temperature and toxicity in murine studies of staphylococcal enterotoxins and toxic shock syndrome toxin 1. Infect Immun (1999) 1.33
Mucosal vaccination with recombinantly attenuated staphylococcal enterotoxin B and protection in a murine model. Infect Immun (2001) 1.23
Inhibition of toxic shock by human monoclonal antibodies against staphylococcal enterotoxin B. PLoS One (2010) 1.03
The staphylococcal enterotoxin (SE) family: SEB and siblings. Virulence (2013) 1.02
Role of T cells and gamma interferon during induction of hypersensitivity to lipopolysaccharide by toxic shock syndrome toxin 1 in mice. Infect Immun (2001) 0.94
Pentoxifylline inhibits superantigen-induced toxic shock and cytokine release. Clin Diagn Lab Immunol (1999) 0.88
Refined structures of three crystal forms of toxic shock syndrome toxin-1 and of a tetramutant with reduced activity. Protein Sci (1997) 0.87
Pirfenidone blocks the in vitro and in vivo effects of staphylococcal enterotoxin B. Infect Immun (2002) 0.87
Temporal sequence and kinetics of proinflammatory and anti-inflammatory cytokine secretion induced by toxic shock syndrome toxin 1 in human peripheral blood mononuclear cells. Infect Immun (2001) 0.85
Toxic shock syndrome toxin-1-mediated toxicity inhibited by neutralizing antibodies late in the course of continual in vivo and in vitro exposure. Toxins (Basel) (2014) 0.82
Clostridium perfringens enterotoxin lacks superantigenic activity but induces an interleukin-6 response from human peripheral blood mononuclear cells. Infect Immun (1997) 0.76
The staphylococcal enterotoxins and their relatives. Science (1990) 11.99
Toxic-shock syndrome associated with phage-group-I Staphylococci. Lancet (1978) 10.25
Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome. J Infect Dis (1981) 8.40
The antigenic structure of proteins: a reappraisal. Annu Rev Immunol (1984) 5.31
T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor. J Exp Med (1992) 4.31
Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses. Crit Rev Microbiol (1990) 3.89
The toxicity of staphylococcal enterotoxin B in mice is mediated by T cells. J Exp Med (1990) 3.31
Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J Infect Dis (1990) 3.20
Crystal structure of staphylococcal enterotoxin B, a superantigen. Nature (1992) 2.84
Selective expansion of T cells expressing V beta 2 in toxic shock syndrome. J Exp Med (1990) 2.71
Purification and some physicochemical properties of toxic-shock toxin. Biochemistry (1983) 2.65
Role of superantigens in human disease. J Infect Dis (1993) 2.62
Toxic shock syndrome toxin 1 as an inducer of human tumor necrosis factors and gamma interferon. J Exp Med (1988) 2.61
Enhancement of host susceptibility to lethal endotoxin shock by staphylococcal pyrogenic exotoxin type C. Infect Immun (1982) 2.43
Mutations defining functional regions of the superantigen staphylococcal enterotoxin B. J Exp Med (1992) 2.38
Induction of human interleukin-1 by toxic-shock-syndrome toxin-1. J Infect Dis (1985) 2.37
Toxin involvement in toxic shock syndrome. J Infect Dis (1986) 1.95
ENHANCEMENT OF BACTERIAL ENDOTOXIN LETHALITY BY STAPHYLOCOCCAL ENTEROTOXIN. J Infect Dis (1964) 1.87
Production of tumor necrosis factor by human monocytes in response to toxic-shock-syndrome toxin-1. J Infect Dis (1988) 1.72
Toxicity of staphylococcal enterotoxins potentiated by lipopolysaccharide: major histocompatibility complex class II molecule dependency and cytokine release. Infect Immun (1993) 1.69
Structural basis of superantigen action inferred from crystal structure of toxic-shock syndrome toxin-1. Nature (1994) 1.67
Toxicity of staphylococcal toxic shock syndrome toxin 1 in rabbits. Infect Immun (1984) 1.60
An evolutionary conserved mechanism of T cell activation by microbial toxins. Evidence for different affinities of T cell receptor-toxin interaction. J Immunol (1991) 1.55
Pathogenesis of the toxic shock syndrome: T cell mediated lethal shock caused by the superantigen TSST-1. Eur J Immunol (1993) 1.54
Staphylococcal enterotoxin B and toxic shock syndrome toxin-1 bind to distinct sites on HLA-DR and HLA-DQ molecules. J Immunol (1989) 1.54
Lack of complete correlation between emetic and T-cell-stimulatory activities of staphylococcal enterotoxins. Infect Immun (1993) 1.47
Structure of toxic shock syndrome toxin 1. Biochemistry (1993) 1.43
Toxicity of tumor necrosis factor is synergistic with gamma-interferon and can be reduced with cyclooxygenase inhibitors. Am J Pathol (1987) 1.37
Isolation of specific and common antibodies to staphylococcal enterotoxins B, C1, and C2. Infect Immun (1980) 1.36
Neutralization of toxic shock syndrome toxin-1 by monoclonal antibodies in vitro and in vivo. Infect Immun (1988) 1.36
The alpha 1 domain of the HLA-DR molecule is essential for high-affinity binding of the toxic shock syndrome toxin-1. Nature (1990) 1.34
Toxicity of recombinant toxic shock syndrome toxin 1 and mutant toxins produced by Staphylococcus aureus in a rabbit infection model of toxic shock syndrome. Infect Immun (1993) 1.33
Mutants of staphylococcal toxic shock syndrome toxin 1: mitogenicity and recognition by a neutralizing monoclonal antibody. Infect Immun (1990) 1.31
Superantigen mediated shock: a cytokine release syndrome. Immunobiology (1993) 1.29
Isolation of specific and common antibodies to staphylococcal enterotoxins A and E by affinity chromatography. Infect Immun (1978) 1.29
Evidence for the involvement of endotoxin in toxic shock syndrome. J Infect Dis (1987) 1.22
Immunobiologic and biochemical properties of mutants of toxic shock syndrome toxin-1. J Immunol (1994) 1.20
Superantigens associated with staphylococcal and streptococcal toxic shock syndrome are potent inducers of tumor necrosis factor-beta synthesis. J Infect Dis (1993) 1.20
Activation of murine T cells by toxic shock syndrome toxin-1. The toxin-binding structures expressed on murine accessory cells are MHC class II molecules. J Immunol (1989) 1.19
Synergistic induction of interleukin-1 by endotoxin and toxic shock syndrome toxin-1 using rat macrophages. Infect Immun (1987) 1.09
Cross-neutralization of staphylococcal and streptococcal pyrogenic toxins by monoclonal and polyclonal antibodies. Infect Immun (1988) 1.06
Enhancement of endotoxin-induced isolated renal tubular cell injury by toxic shock syndrome toxin 1. Am J Pathol (1986) 1.04
Clearance of endotoxin from blood of rabbits injected with staphylococcal toxic shock syndrome toxin-1. Infect Immun (1986) 1.01
Staphylococcal enterotoxin type A internal deletion mutants: serological activity and induction of T-cell proliferation. Infect Immun (1993) 1.00
A mutation at histidine residue 135 of toxic shock syndrome toxin yields an immunogenic protein with minimal toxicity. Infect Immun (1995) 0.99
Immunologic cross-reactivity of type A streptococcal exotoxin (erythrogenic toxin) and staphylococcal enterotoxins B and C1. Infect Immun (1987) 0.98
Production of human and murine interleukin-2 by toxic shock syndrome toxin-1. Immunology (1986) 0.97
Increased susceptibility to staphylococcal enterotoxin B intoxication in mice primed with actinomycin D. Infect Immun (1994) 0.97
Binding of toxic shock syndrome toxin-1 to murine major histocompatibility complex class II molecules. Eur J Immunol (1990) 0.97
Development of a monoclonal antibody capable of interacting with five serotypes of Staphylococcus aureus enterotoxin. Appl Environ Microbiol (1984) 0.96
Possible endotoxemia in rabbits after intravenous injection of Staphylococcus aureus enterotoxin B. J Infect Dis (1977) 0.94
Identification of staphylococcal enterotoxin B sequences important for induction of lymphocyte proliferation by using synthetic peptide fragments of the toxin. Infect Immun (1994) 0.93
Toxic shock syndrome toxin 1 enhances synthesis of endotoxin-induced tumor necrosis factor in mice. Infect Immun (1991) 0.90
Concomitant loss of conformation and superantigenic activity of staphylococcal enterotoxin B deletion mutant proteins. Infect Immun (1993) 0.90
Stimulation of T cells and induction of interferon by toxic shock syndrome toxin 1. Rev Infect Dis (1989) 0.89
Determination of biologically active region in toxic shock syndrome toxin 1. Rev Infect Dis (1989) 0.88
Toxicity of staphylococcal toxic shock syndrome toxin 1 for germ-free and conventional piglets. Rev Infect Dis (1989) 0.85
Bindings of toxic shock syndrome toxin-1 and staphylococcal enterotoxins A, B, and C to rabbit spleen cells. Microbiol Immunol (1989) 0.85
Endotoxin enhancement of toxic shock syndrome toxin 1-induced secretion of interleukin 1 by murine macrophages. Rev Infect Dis (1989) 0.83
Receptors for toxic shock syndrome toxin-1 and staphylococcal enterotoxin A on human blood monocytes. Can J Microbiol (1992) 0.82
Production of tumour necrosis factors by human T cells stimulated by a superantigen, toxic shock syndrome toxin-1. Clin Exp Immunol (1994) 0.81
Identification of binding domains on the superantigen, toxic shock syndrome-1, for class II MHC molecules. Biochem Biophys Res Commun (1993) 0.80
Structure-activity relationship of toxic-shock-syndrome toxin-1: derivation and characterization of immunologically and biologically active fragments. J Infect Dis (1988) 0.80
Identification of functionally active fragments of staphylococcal enterotoxin B. Eur J Biochem (1992) 0.79
Activation of in vitro proliferation of human T cells by a synthetic peptide of toxic shock syndrome toxin 1. J Infect Dis (1991) 0.77
Shigella infection of Henle intestinal epithelial cells: role of the bacterium. Infect Immun (1979) 5.24
Shigella infection of henle intestinal epithelial cells: role of the host cell. Infect Immun (1979) 5.09
Studies on the mode of action of diphtheria toxin. I. Protein synthesis in guinea pig tissues. J Exp Med (1966) 2.22
Production of staphylococcal enterotoxin F and pyrogenic exotoxin C by Staphylococcus aureus isolates from toxic shock syndrome-associated sources. Infect Immun (1983) 2.08
Anomalous high native resistance to athymic mice to bacterial pathogens. Infect Immun (1977) 1.75
Toxicity of staphylococcal enterotoxins potentiated by lipopolysaccharide: major histocompatibility complex class II molecule dependency and cytokine release. Infect Immun (1993) 1.69
Elimination of Leishmania donovani amastigotes by activated macrophages. Infect Immun (1981) 1.58
Phagocytosis and intracellular killing of Staphylococcus aureus by normal mouse peritoneal macrophages. Infect Immun (1975) 1.57
DNA-mediated gene transfer: recombination between cotransferred DNA sequences and recovery of recombinants in a plasmid. Proc Natl Acad Sci U S A (1982) 1.56
Enhanced metabolism of Leishmania donovani amastigotes at acid pH: an adaptation for intracellular growth. Science (1985) 1.48
Studies on the mode of action of diphtheria toxin. III. Effect on subcellular components of protein synthesis from the tissues of intoxicated guinea pigs and rats. J Exp Med (1970) 1.40
Chemical modulation of diphtheria toxin action on cultured mammalian cells. Infect Immun (1975) 1.37
Receptor-mediated entry of diphtheria toxin into monkey kidney (Vero) cells: electron microscopic evaluation. Infect Immun (1985) 1.36
A role for oxygen-dependent mechanisms in killing of Leishmania donovani tissue forms by activated macrophages. J Immunol (1982) 1.36
Interaction of cultured mammalian cells with [125I] diphtheria toxin. Infect Immun (1975) 1.34
Lethal toxin of Bacillus cereus. I. Relationships and nature of toxin, hemolysin, and phospholipase. J Bacteriol (1967) 1.32
The epidemiology of genital colonization with Staphylococcus aureus. Ann Intern Med (1982) 1.32
The effect of neutral and acidic polysaccharides on natural resistance of mice to bacterial challenge. J Infect Dis (1965) 1.32
Studies on the mode of action of diphtheria toxin. II. Protein synthesis in primary heart cell cultures. J Exp Med (1967) 1.31
Mutants of staphylococcal toxic shock syndrome toxin 1: mitogenicity and recognition by a neutralizing monoclonal antibody. Infect Immun (1990) 1.31
Rapid screening assay for toxic shock syndrome toxin production by Staphylococcus aureus. J Clin Microbiol (1984) 1.31
Antibody responses to toxic-shock-syndrome (TSS) toxin by patients with TSS and by healthy staphylococcal carriers. J Infect Dis (1984) 1.28
Autoradiographic evidence for the impermeability of mouse peritoneal macrophages to tritiated streptomycin. J Bacteriol (1967) 1.27
Phagocytosis and intracellular disposition of viable bacteria by the isolated perfused rat liver. J Reticuloendothel Soc (1965) 1.26
Status of bacterial toxins and their nomenclature: need for discipline and clarity of expression. Bacteriol Rev (1967) 1.23
Killing of intraphagocytic Staphylococcus aureus by dihydrostreptomycin entrapped within liposomes. Antimicrob Agents Chemother (1978) 1.20
Independent and synergistic thymocyte proliferative activities of PMA and IL 1. J Immunol (1982) 1.16
Interleukin 1 production by a human acute monocytic leukemia cell line. Cell Immunol (1983) 1.16
Enhancement of carrier-mediated transport after immunologic activation of peritoneal macrophages. J Immunol (1977) 1.16
Visceral leishmaniasis in congenic mice of susceptible and resistant phenotypes: immunosuppression by adherent spleen cells. Infect Immun (1985) 1.15
Staphylococcus aureus: the toxic presence of a pathogen extraordinaire. Curr Med Chem (2009) 1.14
Synergistic induction of interleukin-1 by endotoxin and toxic shock syndrome toxin-1 using rat macrophages. Infect Immun (1987) 1.09
Facilitated uptake of streptomycin by Kupffer cells during phagocytosis. Nature (1967) 1.09
Cell-mediated immune phenomena induced by lymphokines from splenic lymphocytes of mice with chronic staphylococcal infection. Infect Immun (1975) 1.07
Inhibition of protein synthesis after intravenous or intramuscular challenge with diphtheria toxin. Infect Immun (1972) 1.05
Enhanced phagocytosis, killing, and serum sensitivity of Escherichia coli and Staphylococcus aureus treated with sub-MICs of imipenem. Antimicrob Agents Chemother (1988) 1.04
Efficacy of combined immunostimulation and chemotherapy in experimental visceral Leishmaniasis. Am J Trop Med Hyg (1983) 1.02
Staphylococcal enterotoxin B mutants (N23K and F44S): biological effects and vaccine potential in a mouse model. Vaccine (1997) 1.02
Cultural, phagocytic, and bactericidal characteristics of peritoneal macrophages. J Reticuloendothel Soc (1973) 1.00
Crystal structure of a biologically inactive mutant of toxic shock syndrome toxin-1 at 2.5 A resolution. Protein Sci (1996) 0.98
Human interleukin 1 mediates cartilage matrix degradation. Cell Immunol (1985) 0.98
Evidence for pseudomonas exotoxin A receptors on plasma membrane of toxin-sensitive lm fibroblasts. Infect Immun (1984) 0.97
Protection of rabbits in an infection model of toxic shock syndrome (TSS) by a TSS toxin-1-specific monoclonal antibody. Infect Immun (1988) 0.96
Absorption of botulinal toxin from the gastrointestinal tract. Rev Infect Dis (1980) 0.93
Studies on the mode of action of diphtheria toxin. V. Protein metabolism in a guinea pig model simulating chronic diphtheritic toxemia. Infect Immun (1973) 0.93
Synergistic effect of glucantime and a liposome-encapsulated muramyl dipeptide analog in therapy of experimental visceral leishmaniasis. Infect Immun (1985) 0.91
Visceral leishmaniasis in congenic mice of susceptible and resistant phenotypes: T-lymphocyte-mediated immunosuppression. Infect Immun (1985) 0.90
Augmentation of glucose transport in macrophages after particle ingestion. Infect Immun (1974) 0.90
A macrophage-derived factor that inhibits the production and action of interleukin 2. J Leukoc Biol (1985) 0.89
Specificity of diphtheria toxin action on heart and muscle tissues of Guinea pigs. Infect Immun (1970) 0.89
Studies on the effect of diphtheria toxin on protein synthesis in mice. J Med Microbiol (1973) 0.89
Toxic shock syndrome: a microbiological perspective. Surv Synth Pathol Res (1984) 0.88
Differential immune responses to staphylococcal enterotoxin B mutations in a hydrophobic loop dominating the interface with major histocompatibility complex class II receptors. J Infect Dis (1998) 0.87
Specific reversal of diphtheria toxin mediated inhibition of protein synthesis in guinea pig tissues. Biochem Biophys Res Commun (1970) 0.87
Immunosuppression associated with visceral leishmaniasis of hamsters. Parasite Immunol (1985) 0.87
Enzymes of carbohydrate metabolism in Leishmania donovani amastigotes. J Protozool (1984) 0.86
Analysis of the heterogeneity of the mouse H-2K, D, and L gene products. J Immunol (1980) 0.86
Development of protective immunity against bacterial and viral infections in tumor-bearing mice coincident with suppression of tumor immunity. J Reticuloendothel Soc (1982) 0.86
Estimate of myocardial damage induced by diphtheria toxin. J Lab Clin Med (1973) 0.85
Uptake of diphtheria toxin and its fragment A moiety by mammalian cells in culture. Infect Immun (1976) 0.85
Staphylococcal enterotoxins fail to disrupt membrane integrity or synthetic functions of Henle 407 intestinal cells. Infect Immun (1981) 0.84
Structural analysis of the charge heterogeneity of human interleukin 1. Arch Biochem Biophys (1984) 0.84
Acquired immunity against mouse typhoid: genetic restriction and comparative efficacy of ribosomal and conventional vaccines. J Med Microbiol (1981) 0.84
Familial hypersensitivity pneumonitis induced by Bacillus subtilis. Am Rev Respir Dis (1980) 0.84
Specific receptor binding of staphylococcal enterotoxins by murine splenic lymphocytes. Infect Immun (1981) 0.84
Human interleukin 1. Crit Rev Immunol (1986) 0.83
Endotoxin enhancement of toxic shock syndrome toxin 1-induced secretion of interleukin 1 by murine macrophages. Rev Infect Dis (1989) 0.83
Membrane transport by mouse and guinea pig macrophages: characteristics of the glucose transport system. J Reticuloendothel Soc (1975) 0.82
Role of a carboxy-terminal site of toxic shock syndrome toxin 1 in eliciting immune responses of human peripheral blood mononuclear cells. Infect Immun (1995) 0.81
Tolerance limits of the toad, Bufo marinus, in South Florida. Comp Biochem Physiol (1970) 0.81
Kinetics of phagocytosis and killing of E. coli by murine macrophages in presence of different serum preparations. Microbiologica (1988) 0.80
Membrane transport of amino acids and hexose by guinea pig and mouse phagocytes. J Reticuloendothel Soc (1977) 0.80
Studies on the mode of action of diphtheria toxin. VI. Inhibition of protein synthesis induced by local infection with toxingenic Corynebacterium diphtheriae. Proc Soc Exp Biol Med (1973) 0.80
Impaired resistance to bacterial infection after tumor implant is traced to lactic dehydrogenase virus. Infect Immun (1980) 0.80
Enhancement of Glucantime therapy of murine Leishmania donovani infection by a synthetic immunopotentiating compound (CP-46,665-1). Am J Trop Med Hyg (1985) 0.80
Membrane transport by guinea pig peritoneal exudate leukocytes: effect of phagocytosis on hexose and amino acid transport. J Cell Physiol (1977) 0.80
Purification to homogeneity of biologically active human interleukin 1. Prep Biochem (1985) 0.79
Passive protection of rabbits infected with toxic shock syndrome-associated strains of Staphylococcus aureus by monoclonal antibody to toxic shock syndrome toxin 1. Rev Infect Dis (1989) 0.79
A toxic shock syndrome toxin 1 mutant that defines a functional site critical for T-cell activation. Infect Immun (1995) 0.79
The localization of Staphylococcus aureus in mice by whole-animal radioautography. Am J Pathol (1966) 0.79
Leishmania donovani infection in athymic mice derived from parental strains of the susceptible (Lshs) or resistant (Lshr) phenotype. J Leukoc Biol (1984) 0.78
Attempts to implicate the central nervous system as a primary site of action for Bacillus anthracis lethal toxin. Fed Proc (1967) 0.78
Interaction of toxin of Corynebacterium diphtheriae with phagocytes from susceptible and resistant species. J Infect Dis (1975) 0.78
Staphylococcal enterotoxin induced mitogenesis: toxin binding and cell-cell interactions. Microbiologica (1983) 0.78
Two-dimensional gel comparisons of murine H-2D region-associated antigens of different H-2 haplotypes. J Immunol (1983) 0.77
Effects of solid tumors on the resistance of mice to viral and bacterial infections. Proc Soc Exp Biol Med (1982) 0.77
Activation of in vitro proliferation of human T cells by a synthetic peptide of toxic shock syndrome toxin 1. J Infect Dis (1991) 0.77
Cyclosporin A treatment converts Leishmania donovani-infected C57BL/10 (curing) mice to a noncuring phenotype. Infect Immun (1990) 0.76
A fas antigen receptor mutation allows development of toxic shock syndrome toxin-1-induced lethal shock in V beta 8.2 T-cell receptor transgenic mice. Pathobiology (1995) 0.76
Immunoblots for detection of toxic shock syndrome toxin 1 produced by Staphylococcus aureus. J Clin Microbiol (1990) 0.75
Antigenic stimulation of lymphocytes. II. Immunogenicity of dinitrophenyl-polyethylene oxide antigens. Cell Immunol (1979) 0.75
Studies on the mode of action of diphtheria toxin. Protein synthesis in guinea pig tissues and primary heart cell cultures. Ann Ist Super Sanita (1968) 0.75
Carboxymethylcellulose, tampons, and staphylococci. Lancet (1983) 0.75
Ecological correlation of water loss in burrowing reptiles. Nature (1968) 0.75
Biochemical characterization of interleukin 1 from a human monocytic cell line. J Leukoc Biol (1985) 0.75
Relationship of superabsorbant tampons and the toxic shock syndrome. Am J Obstet Gynecol (1984) 0.75
Thioglycollate elicited macrophages demonstrate enhanced virus replication and depressed bacterial killing. Microbiologica (1987) 0.75
Antigenic stimulation of lymphocytes. I. Calorimetric exploration of metabolic responses. Cell Immunol (1976) 0.75
Divalent mitogens as tools in the study of commitment of lymphocytes to proliferation. Biochem Biophys Res Commun (1978) 0.75
A simple method for electrophoretic analysis of cell surface glycoproteins based on concanavalin A binding. J Immunol Methods (1982) 0.75